Progress in clinical fibrinolysis
- 1 March 1997
- journal article
- Published by Elsevier in Fibrinolysis and Proteolysis
- Vol. 11 (2) , 67-84
- https://doi.org/10.1016/s0268-9499(97)80098-7
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissuesCancer, 1996
- Prognostic value of plasminogen activators and their inhibitors in colorectal cancerEuropean Journal Of Cancer, 1995
- Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarctionJournal of the American College of Cardiology, 1994
- Relationship of the plasminogen activator/plasmin cascade to osteoclast invasion and mineral resorption in explanted fetal metatarsal bonesJournal of Bone and Mineral Research, 1994
- Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cellsKidney International, 1994
- Pro‐urokinase and prekallikrein are both associated with plateletsFEBS Letters, 1993
- Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumorsJournal of Neuro-Oncology, 1993
- Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseasesArthritis & Rheumatism, 1992
- Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion eventHuman Genetics, 1992
- A new model of osteoarthritis in rabbitsArthritis & Rheumatism, 1983